Restriction endonuclease analysis of varicella‐zoster vaccine virus and wild‐type dnas

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Journal of Medical Virology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jmv.1890090110PMID 6278073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Live attenuated varicella vaccine.

  1984cited by this paper
• Varicella-zoster virus vaccine DNA differs from the parental virus DNA

  1981cited by this paper
• Structure of varicella-zoster virus DNA

  1981cited by this paper
• Restriction endonuclease analysis of the DNA from varicella-zoster virus: stability of the DNA after passage in vitro.

  1981cited by this paper
• Molecular epidemiology of cytomegalovirus infections in women and their infants.

  1980cited by this paper
• Live attenuated Varicella-Zoster vaccine.

  1980cited by this paper
• Analysis of the DNAs from seven varicella-zoster virus isolates

  1979cited by this paper
• Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA.

  1979cited by this paper
• Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak.

  1978cited by this paper
• Analysis by restriction enzyme cleavage of human varicella-zoster virus DNAs.

  1977cited by this paper
• Application of a live varicella vaccine in children with acute leukemia or other malignant diseases.

  1977cited by this paper
• Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1

  1976cited by this paper
• Nucleic acid renaturation and restriction endonuclease cleavage analyses show that the DNAs of a transforming and a nontransforming strain of Epstein-Barr virus share approximately 90% of their nucleotide sequences

  1976cited by this paper
• Anatomy of herpes simplex virus DNA. III. Characterization of defective DNA molecules and biological properties of virus populations containing them

  1975cited by this paper
• Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites.

  1975cited by this paper
• Analysis of DNA of defective herpes simplex virus type 1 by restriction endonuclease cleavage and nucleic acid hybridization.

  1975cited by this paper
• Development of a live attenuated varicella vaccine.

  1975cited by this paper
• Varicella in children with cancer: Seventy-seven cases.

  1975cited by this paper
• Comparative studies on tomato aspermy and cucumber mosaic viruses. II. Virus stability.

  1974cited by this paper
• Characterization of defective interfering viral particles present in a population of pseudorabies virions.

  1974cited by this paper
• Defective virions of herpes simplex viruses.

  1973cited by this paper
• Herpes virus infections of non-human primates: a review.

  1969cited by this paper
• Herpes virus infections of non-human primates: a review.

  1969cited by this paper
• The activation of varicella-zoster virus infections by immunosuppressive therapy.

  1966cited by this paper
• [Varicella virus].

  1955cited by this paper
• Serial Propagation in vitro of Agents Producing Inclusion Bodies Derived from Varicella and Herpes Zoster.∗

  1953cited by this paper

• Meningitis without Rash after Reactivation of Varicella Vaccine Strain in a 12-Year-Old Immunocompetent Boy

  2023cites this paper
• Varicella-Zoster Virus-Genetics, Molecular Evolution and Recombination.

  2021cites this paper
• Molecular Aspects of Varicella-Zoster Virus Latency

  2018cites this paper
• Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation.

  2018cites this paper
• VZV molecular epidemiology.

  2010influential citation
• A real‐time PCR assay to identify and discriminate among wild‐type and vaccine strains of varicella‐zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses

  2009cites this paper
• Varicella.

  2006cites this paper
• Genome variation among varicella-zoster virus isolates derived from different individuals and from the same individuals

  2005cites this paper
• Preventing Varicella-Zoster Disease

  2005cites this paper
• Equine herpesvirus type 1 (EHV-1) induced abortions and paralysis in a Lipizzaner stud: a contribution to the classification of equine herpesviruses

  2005cites this paper
• Comparison of contagious ecthyma virus genomes by restriction endonucleases

  2005cites this paper
• HAEMOPHILUS INFLUENZAE TYPE B: THE BURDEN IN ASIA

  2004cites this paper
• A real-time PCR assay for the detection of varicella-zoster virus DNA and differentiation of vaccine, wild-type and control strains.

  2003cites this paper
• Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR.

  2003cites this paper
• Rapid and accurate viral diagnosis

  2002cites this paper
• Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates.

  2001cites this paper
• Erdheim-Chester Disease with Extensive Marrow Necrosis

  2001cites this paper
• [Skin manifestations of Erdheim-Chester disease. Case report and review of the literature].

  2001cites this paper
• Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome

  2000cites this paper
• Comparison between of the attenuated BR-Oka and the wild type strain of Varicella Zoster Virus (VZV) on the DNA level

  2000cites this paper
• Stability of a varicella-zoster virus glycoprotein E epitope

  2000cites this paper
• Erdheim-Chester disease: a case report and literature overview

  1999cites this paper
• Determination of extent and activity with radionuclide imaging in Erdheim-Chester disease.

  1999cites this paper
• Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis.

  1998cites this paper
• Erdheim–Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone

  1997cites this paper
• Erdheim‐Chester Disease Clinical and Radiologic Characteristics of 59 Cases

  1996cites this paper
• Identification and analyses of glycoprotein B of human herpesvirus 7.

  1996cites this paper
• Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.

  1996cites this paper
• Live attenuated varicella vaccine.

  1996cites this paper
• The varicella vaccine. Vaccine development.

  1996cites this paper
• Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada.

  1996cites this paper
• The varicella vaccine. Clinical trials in immunocompromised individuals.

  1996cites this paper
• Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years.

  1996cites this paper
• The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox.

  1996cites this paper
• CLINICAL TRIALS IN IMMUNOCOMPROMISED INDIVIDUALS

  1996cites this paper
• Herpes zoster in a normal child after varicella vaccination

  1995cites this paper
• Retroperitoneal xanthogranuloma in a patient with Erdheim-Chester disease.

  1994cites this paper
• Identification of human herpesvirus 6 uracil-DNA glycosylase gene.

  1994cites this paper
• Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.

  1994cites this paper
• [Erdheim-Chester disease: report of a case, review of the literature and discussion of the relation to Langerhans-cell histiocytosis].

  1993cites this paper
• Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates

  1992cites this paper
• Current status and prospects of live varicella vaccine.

  1992cites this paper
• Varicella vaccine: the American experience.

  1992cites this paper
• Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization

  1991cites this paper
• Lessons from Varicella Vaccine

  1991cites this paper
• Erdheim-Chester disease. Case report with autopsy findings.

  1991cites this paper
• Restriction endonuclease analysis of varicella-zoster virus DNAs.

  1991cites this paper
• A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V).

  1991cites this paper
• Varicella-zoster virus. The Fourteenth Fleming lecture.

  1991cites this paper
• Medical Virology 10

  1991cites this paper
• [Erdheim-Chester disease].

  1991cites this paper
• Differentiation of vaccine strains and Georgia field isolates of infectious laryngotracheitis virus by their restriction endonuclease fragment patterns.

  1990cites this paper
• A rapid and simplified micromethod for subtyping varicella‐zoster virus

  1990cites this paper
• Viral vaccines of the future.

  1990cites this paper
• Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.

  1990cites this paper
• Infections of the Nervous System

  1990cites this paper
• Genomic heterogeneity of human herpesvirus 6 isolates.

  1990cites this paper
• A live varicella vaccine.

  1990cites this paper
• Differentiation between the oka varicella vaccine virus and American wild-type varicella-zoster virus (VZV).

  1990cites this paper
• Molecular biology of varicella zoster virus.

  1990cites this paper
• AIDS and Other Immunocompromised States

  1990cites this paper
• Differentiation of vaccine and field strains of bovine herpesvirus type 1 by restriction endonuclease analysis.

  1990cites this paper
• Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.

  1990cites this paper
• Herpes zoster in an adult recipient of live attenuated varicella vaccine.

  1989cites this paper
• Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.

  1989cites this paper
• Restriction fragment differences between the genomes of the Oka varicella vaccine virus and american wild‐type varicella‐zoster virus

  1989cites this paper
• Distribution of varicella-zoster virus strains carrying a PstI-site-less mutation in Japan and DNA change responsible for the mutation.

  1989cites this paper
• Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.

  1989cites this paper
• Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.

  1989cites this paper
• Variation of R1 repeated sequence present in open reading frame 11 of varicella-zoster virus strains

  1988cites this paper
• Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts.

  1988cites this paper
• Recombination in tissue culture between varicella‐zoster virus strains

  1988cites this paper
• Xanthoma of bone.

  1988cites this paper
• Immunization of healthy adults with live attenuated varicella vaccine.

  1988cites this paper
• Herpesviridae: Varicella-Zoster Virus

  1988cites this paper
• Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA

  1988cites this paper
• Varicella-zoster virus DNA from persistently infected cells contains novel tandem duplications.

  1988cites this paper
• Development and Characteristics of Oka Strain of Live Varicella Vaccine

  1988cites this paper
• Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.

  1987cites this paper
• Live attenuated varicella vaccine.

  1987cites this paper
• Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus

  1987cites this paper
• Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.

  1987cites this paper
• Live attenuated varicella vaccine.

  1987cites this paper
• Clinical overview of varicella vaccine: development and early studies.

  1986cites this paper
• The complete DNA sequence of varicella-zoster virus.

  1986cites this paper
• Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI.

  1986cites this paper
• Physical characterization of the genome of feline herpesvirus-1.

  1986cites this paper
• Prospects for a Varicella-Zoster Vaccine

  1986cites this paper
• Live attenuated varicella vaccine use in immunocompromised children and adults.

  1986cites this paper
• A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.

  1985cites this paper
• Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia.

  1985cites this paper
• Transcription mapping of the varicella-zoster virus genome

  1985cites this paper
• Development of a Live Attenuated Vaccine Against Varicella

  1985cites this paper
• The Herpesviruses

  1985cites this paper
• Live attenuated varicella vaccine.

  1985cites this paper
• Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients.

  1985cites this paper
• Varicella vaccine: case studies.

  1985cites this paper
• Physical maps of varicella-zoster virus DNA derived with 11 restriction enzymes

  1984cites this paper
• Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.

  1984cites this paper
• Clinical reinfection with varicella-zoster virus.

  1984cites this paper